T. Utsunomiya et al., Clinicopathological characteristics of patients with extrahepatic recurrence following a hepatectomy for hepatocellular carcinoma, HEP-GASTRO, 48(40), 2001, pp. 1088-1093
Background/Aims: None of the previous studies have compared the prognosis o
r clinicopathological factors between the patients with extrahepatic recurr
ence and those with intrahepatic recurrence of hepatocellular carcinoma aft
er a hepatic resection.
Methodology: The clinicopathological features and prognoses of patients wit
h extrahepatic recurrence after a curative hepatectomy for hepatocellular c
arcinoma were investigated.
Results: Twenty-three patients with extrahepatic recurrence had more advanc
ed-stage hepatocellular carcinoma at the primary operation compared to 186
patients with intrahepatic recurrence. After adjusting for tumor size, the
prognosis of the 2 groups were comparable. However, among the patients with
hepatocellular carcinoma exceeding 5cm in diameter, the number of patients
whose plasma levels of des-gamma -carboxy prothrombin was higher than 2.0
AU/mL in the patients with extra-hepatic recurrence (62.5%) was significant
ly more (P <0.05) than that in the patients with intrahepatic recurrence (2
0.0%). On the other hand, the prognosis of the 13 patients with extrahepati
c recurrence alone was significantly better than in the 10 patients with bo
th intrahepatic and extrahepatic recurrences. The prognoses of the 3 patien
ts who underwent a surgical resection for isolated extrahepatic recurrence
were markedly better than that of the remaining 10 patients only treated pa
lliatively.
Conclusions: If patients have tumors exceeding 5cm. in diameter and their p
lasma levels of des-gamma -carboxy prothrombin are higher than 2.0 AU/mL, m
ore careful follow-up examinations than usual may thus be necessary in orde
r to detect extrahepatic recurrence as early as possible. Furthermore, a su
rgical resection for the isolated extrahepatic recurrence of hepatocellular
carcinoma is also recommended to produce long-term survivors.